Phialophora asteris
Phialophora asteris
Description
Phialophora asteris is a specialized fungal pathogen belonging to the kingdom Fungi and the phylum Ascomycota. It is the primary causal agent of aster wilt, a severe vascular disease that targets various plants in the Asteraceae family, most notably China asters (Callistephus chinensis) and chrysanthemums.
The disease manifests as a progressive wilt, starting with chlorosis of the lower leaves, followed by wilting and eventual death of the entire plant. A key diagnostic symptom is the browning of the vascular tissue within the stem, which can be easily observed in a cross-section of an infected plant. This blockage prevents the transport of water and nutrients, leading to systemic collapse.
The biology of the pathogen is centered on its ability to persist in the soil for several years through chlamydospores and mycelium. Infection typically begins when the fungus enters the host through root wounds or root hairs. Once inside, the fungus colonizes the xylem vessels, where it reproduces and produces metabolites that further impede host water conduction.
Environmental conditions such as high soil moisture and moderate temperatures are ideal for the development and spread of Phialophora asteris. The pathogen is easily disseminated through infested soil, contaminated gardening equipment, and diseased plant debris. Because it survives well in the soil, it poses a significant threat to long-term site health if left unmanaged.
Controlling the spread of this pathogen requires strict adherence to cultural practices and chemical interventions. Key management strategies include:
- Implementing long-term crop rotation schemes to avoid susceptible hosts for at least 5 to 7 years.
- Ensuring the use of disease-free, certified nursery stock.
- Prompt removal and destruction of infected plants, including surrounding soil.
- Improving soil drainage and optimizing nitrogen levels to reduce stress on host plants.
- Applying preventive systemic fungicides in high-risk areas.
Вызывает болезни · 1
Discussion
No discussions yet — be the first.